(firstQuint)A Safety Comparison of Iopromide and Iodixanol in Renal Impaired Patients.

 In the diagnosis and treatment of coronary heart disease, patients should undergo cardiac angiography or percutaneous coronary intervention (PCI).

 In those procedures, the investigators should use the contrast media, and it may cause kidney toxicity especially in the patients with chronic renal insufficiency.

.

 A Safety Comparison of Iopromide and Iodixanol in Renal Impaired Patients@highlight

The investigators intend to find out which contrast agent has less kidney toxicity in renal impaired patients undergoing cardiac angiography or percutaneous coronary intervention (PCI).

